Clinical Trial Update: A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study comparing two forms of PF-07081532 in adults who are overweight or obese; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• PF-07081532

Snippet

Sponsor: Pfizer | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED | Results posted: 2024-08-09